BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19031968)

  • 1. Telomerase activity in head and neck cancer.
    Kunická Z; Mucha I; Fajkus J
    Anticancer Res; 2008; 28(5B):3125-9. PubMed ID: 19031968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
    Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
    Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
    He GP; Shui QL; Huang Y; Zhang SZ; Yu H
    Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients.
    Lee BJ; Wang SG; Choi JS; Lee JC; Goh EK; Kim MG
    Am J Clin Oncol; 2006 Apr; 29(2):163-7. PubMed ID: 16601436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
    Mao L; El-Naggar AK; Fan YH; Lee JS; Lippman SM; Kayser S; Lotan R; Hong WK
    Cancer Res; 1996 Dec; 56(24):5600-4. PubMed ID: 8971162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck.
    Koscielny S; Eggeling Fv; Dahse R; Fiedler W
    J Oral Pathol Med; 2004 Oct; 33(9):538-42. PubMed ID: 15357674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Telomerase activity in human gastric and colorectal cancer].
    Chen W; Zhang Q; Wan D
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):261-3. PubMed ID: 10920978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.
    Gertler R; Doll D; Maak M; Feith M; Rosenberg R
    Cancer; 2008 May; 112(10):2173-80. PubMed ID: 18348304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Telomerase activity as marker of superficial tumor of the bladder].
    Arias Fúnez F; Fernández Fernández E; Escudero Barrilero A; Moyano Jato A; Caso Peláez E
    Arch Esp Urol; 2000 Apr; 53(3):231-6. PubMed ID: 10851728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma.
    Liao CT; Tung-Chieh Chang J; Wang HM; Chen IH; Lin CY; Chen TM; Hsieh LL; Cheng AJ
    Head Neck; 2004 Jun; 26(6):504-12. PubMed ID: 15162351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of telomerase activity in basal cell carcinomas and in tumour-free surgical margins.
    Fabricius EM; Bezeluk A; Kruse-Boitschenko U; Wildner GP; Klein M
    Int J Oncol; 2003 Nov; 23(5):1389-99. PubMed ID: 14532981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of telomerase activity level in human non-small-cell lung cancer].
    Yang HZ; Hu CP; Su XL
    Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):549-50. PubMed ID: 12536537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of telomerase activity in prostate cancer by needle biopsy.
    Takahashi C; Miyagawa I; Kumano S; Oshimura M
    Eur Urol; 1997; 32(4):494-8. PubMed ID: 9412813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity is upregulated in laryngeal squamous cell carcinoma.
    Curran AJ; Gullane PJ; Irish J; Macmillan C; Freeman J; Kamel-Reid S
    Laryngoscope; 2000 Mar; 110(3 Pt 1):391-6. PubMed ID: 10718425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity in Malaysian patients with central nervous system tumors.
    Isa MN; Sulong S; Sidek MR; George PJ; Abdullah JM
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):872-6. PubMed ID: 15115103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity analysis of esophageal carcinoma using microdissection-TRAP assay.
    Li C; Liang Y; Wu M; Xu L; Cai W
    Chin Med J (Engl); 2002 Sep; 115(9):1405-8. PubMed ID: 12411123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity in phyllodes tumours.
    Mokbel K; Ghilchik M; Parris CN; Newbold RF
    Eur J Surg Oncol; 1999 Aug; 25(4):352-5. PubMed ID: 10419703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer.
    Bautista CV; Felis CP; Espinet JM; García JB; Salas JV
    Dis Colon Rectum; 2007 May; 50(5):611-20. PubMed ID: 17297554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity in stage II colorectal carcinoma.
    Kawanishi-Tabata R; Lopez F; Fratantonio S; Kim N; Goldblum J; Tubbs R; Elson P; Lavery I; Bukowski RM; Ganapathi R; Ganapathi MK
    Cancer; 2002 Nov; 95(9):1834-9. PubMed ID: 12404275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking.
    Getliffe KM; Al Dulaimi D; Martin-Ruiz C; Holder RL; von Zglinicki T; Morris A; Nwokolo CU
    Aliment Pharmacol Ther; 2005 Jan; 21(2):121-31. PubMed ID: 15679761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.